HR 7346 · 117th Congress · Health

John W. Walsh Alpha-1 Home Infusion Act of 2022

Introduced 2022-03-31· Sponsored by Rep. Salazar, Maria Elvira [R-FL-27]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2022-04-01)

Plain Language Summary

[AI summary unavailable — showing source text] John W. Walsh Alpha-1 Home Infusion Act of 2022 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (15)

12 Democrats3 Republicans
Rep. Pingree, Chellie [D-ME-1]ME
Rep. Higgins, Brian [D-NY-26]NY
Rep. Wasserman Schultz, Debbie [D-FL-23]FL
Rep. Tonko, Paul [D-NY-20]NY
Rep. Connolly, Gerald E. [D-VA-11]VA
Rep. Posey, Bill [R-FL-8]FL
Rep. Jacobs, Chris [R-NY-27]NY
Rep. Jones, Mondaire [D-NY-17]NY
Rep. Panetta, Jimmy [D-CA-20]CA
Rep. Owens, Burgess [R-UT-4]UT
Rep. Thompson, Mike [D-CA-5]CA
Rep. Keating, William R. [D-MA-9]MA
Rep. Ross, Deborah K. [D-NC-2]NC
Rep. Yarmuth, John A. [D-KY-3]KY
Rep. Larson, John B. [D-CT-1]CT